Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.10 -0.03 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agios Pharmaceuticals (AGIO) Prepaid Assets (2012 - 2026)

Agios Pharmaceuticals' (AGIO) quarterly Prepaid Assets came in at $45.7 million in Q2 2026, up 2.31% YoY from $44.7 million in Q2 2025, and down 1.85% on a QoQ basis from $46.6 million in Q1 2026.

Analysis

Agios Pharmaceuticals (AGIO) Prepaid Assets (2012 - 2026) Analysis & Trends

Agios Pharmaceuticals (AGIO) has 15 years of Prepaid Assets data on file, last reported at $45.7 million in Q2 2026.

  • Quarterly Prepaid Assets rose 2.31% year-over-year to $45.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $45.7 million (up 2.31% YoY) and the FY2025 annual result came in at $44.1 million, up 9.87% from the prior year.
  • Prepaid Assets slipped to $45.7 million in Q2 2026, from $46.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $46.6 million in Q1 2026 to a low of $34.5 million in Q2 2024.
  • A 5-year average of $41.2 million and a median of $41.2 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets soared 121.55% — and 2023, when it declined 17.37%.
  • Tracing AGIO's Prepaid Assets over 5 years: stood at $39.0 million in 2022, then slipped by 10.1% to $35.0 million in 2023, then advanced by 14.69% to $40.2 million in 2024, then rose by 9.87% to $44.1 million in 2025, then climbed by 3.61% to $45.7 million in 2026.
  • The last three Prepaid Assets figures came in at $45.7 million (Q2 2026), $46.6 million (Q1 2026), and $44.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Agios Pharmaceuticals 1.97 Bn 1.97 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.72 Mn
Mar 31, 2026 46.59 Mn
Dec 31, 2025 44.13 Mn
Sep 30, 2025 43.19 Mn
Jun 30, 2025 44.69 Mn
Mar 31, 2025 42.29 Mn
Dec 31, 2024 40.17 Mn
Sep 30, 2024 39.89 Mn
Jun 30, 2024 34.54 Mn
Mar 31, 2024 39.11 Mn
Dec 31, 2023 35.02 Mn
Sep 30, 2023 38.41 Mn
Jun 30, 2023 36.75 Mn
Mar 31, 2023 39.30 Mn
Dec 31, 2022 38.96 Mn
Sep 30, 2022 46.49 Mn
Jun 30, 2022 42.34 Mn
Mar 31, 2022 43.23 Mn
Dec 31, 2021 39.84 Mn
Sep 30, 2021 32.24 Mn